Market brief — June 29, 2026

Friday, US markets closed in slight decline as the S&P 500 ended at 7,354.02 (-0.05%) and the Nasdaq at 25,297.62 (-0.24%), while European indices showed weakness with the CAC 40 falling 0.55% to 8,384.87 and the DAX dropping 1.29% to 24,671.22^[1]. The Euro Stoxx 50 also retreated 0.73% to 6,221.55, reflecting a systematic unwind of large-cap semiconductor valuations driven by repricing of the Fed’s rate path amid sticky inflation expectations^[1][4]. Overnight, Asia experienced a violent tech-led selloff, with the Nikkei falling sharply and Korea’s KOSPI collapsing, signaling a sharp risk-off rotation ahead of US jobs data this week^[1]. This divergence confirms a shift from crowded tech longs toward cyclicals and biotech, with yields firm, the dollar stable, and credit spreads widening slightly as positioning de-risks^[1].

Macro flows indicate a rotation out of AI-driven tech momentum as investors recalibrate optimism over artificial intelligence profits following volatile moves in semiconductor shares^[1]. The market regime remains dominated by inflation expectations and central bank signaling, with Fed funds futures now indicating better-than-even odds of a rate hike by September, reversing earlier hopes for cuts^[1]. Cross-asset confirmation shows defensive sectors gaining ground while oil pares gains, with Brent staying near $72 a barrel as geopolitical tensions ease after reports of resumed peace talks between the US and Iran^[3]. The move appears systematic, driven by CTA/volatility models reacting to the hawkish Fed tilt, rather than discretionary risk-taking.

Today’s Cash Scanner TOP 10 reveals idiosyncratic momentum in US biotechnology and healthcare, with four biotech firms dominating the list: Cogent Biosciences (COGT) with a score of 45 and a vortex↑ signal, Relay Therapeutics (RLAY) scoring 45 with KST↑, Beam Therapeutics (BEAM) at 45 with KST↑, and Ironwood Pharmaceutical (IRWD) surging 7.6% with a breakout 20j signal^[1]. TELADOC INC (TDOC) leads with a 6.1% gap and a BB squeeze↑, while Assd Banc-Corp Rg (ASB) shows a 1.4% gap with ADX strength at 28^[1]. The sector mix is heavily concentrated in US biotechnology and healthcare, suggesting early regime shifts toward defensive growth amid tech volatility, aligning with the broader de-risking flow.

This week’s agenda centers on US June employment data, expected to rise by 110,000 jobs, which could raise prospects for near-term rate hikes and add volatility to the stock market already on edge from tech swings^[1]. No major economic reports are scheduled for Monday, but the jobs data will be critical for indexing the federal funds rate target range^[8]. The impact could move rates expectations significantly, potentially triggering further volatility in equity indices if the data surprises.

Key risks include a jobs data surprise that could accelerate Fed tightening, a central bank shift toward more hawkish policy, or a liquidity event in tech shares as AI boom risks a global financial crash, according to central banker warnings^[7]. Geopolitical escalation, though currently eased, remains a potential trigger if peace talks falter.

Actionable lines: Watch the S&P 500 for a breakout above 7,380 with confirmation from rising yields, or a breakdown below 7,320 if tech volatility persists; consider long positions in biotech tickers like Cogent Biosciences (COGT) or Ironwood Pharmaceutical (IRWD) if volume sustains above average; and monitor the Nasdaq for a reversal above 25,400 if AI optimism returns.

Bonne journée aux p&l makers.